litlas
ログインアカウント作成

Harpreet Wasan

1993–2025 年に発表

105
論文数
26,092
被引用数
61
h 指数
101
i10 指数

被引用数

Harpreet Wasan の年別被引用数1939 年: 被引用 2 件1979 年: 被引用 1 件1991 年: 被引用 1 件1994 年: 被引用 2 件1995 年: 被引用 4 件1996 年: 被引用 9 件1997 年: 被引用 13 件1998 年: 被引用 20 件1999 年: 被引用 18 件2000 年: 被引用 17 件2001 年: 被引用 15 件2002 年: 被引用 15 件2003 年: 被引用 23 件2004 年: 被引用 25 件2005 年: 被引用 22 件2006 年: 被引用 26 件2007 年: 被引用 17 件2008 年: 被引用 31 件2009 年: 被引用 35 件2010 年: 被引用 47 件2011 年: 被引用 64 件2012 年: 被引用 91 件2013 年: 被引用 87 件2014 年: 被引用 118 件2015 年: 被引用 122 件2016 年: 被引用 122 件2017 年: 被引用 167 件2018 年: 被引用 171 件2019 年: 被引用 850 件2020 年: 被引用 1,264 件2021 年: 被引用 1,203 件2022 年: 被引用 917 件2023 年: 被引用 653 件2024 年: 被引用 1,165 件2025 年: 被引用 528 件2026 年: 被引用 14 件1940〜1978 年は被引用が無いため表示していません1980〜1990 年は被引用が無いため表示していません1992〜1993 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,108 件、この内訳の 19.6%中国: 引用元論文 1,091 件、この内訳の 10.1%イタリア: 引用元論文 864 件、この内訳の 8%イギリス: 引用元論文 752 件、この内訳の 7%ドイツ: 引用元論文 703 件、この内訳の 6.5%日本: 引用元論文 550 件、この内訳の 5.1%フランス: 引用元論文 542 件、この内訳の 5%スペイン: 引用元論文 431 件、この内訳の 4%オランダ: 引用元論文 409 件、この内訳の 3.8%韓国: 引用元論文 260 件、この内訳の 2.4%カナダ: 引用元論文 258 件、この内訳の 2.4%オーストラリア: 引用元論文 236 件、この内訳の 2.2%
0%19.6%その他 23.9%

機関

分野

  • Medicine80.5%
  • Biochemistry, Genetics and Molecular Biology15.6%
  • Immunology and Microbiology1.2%
  • Engineering0.7%
  • Computer Science0.4%
  • Materials Science0.3%
  • その他1.3%

トピック

  • Cholangiocarcinoma and Gallbladder Cancer Studies10.9%
  • Pancreatic and Hepatic Oncology Research8.4%
  • Colorectal Cancer Treatments and Studies6.5%
  • Gallbladder and Bile Duct Disorders5.2%
  • Hepatocellular Carcinoma Treatment and Prognosis5.1%
  • Cancer Genomics and Diagnostics4%
  • その他59.9%

共著者

全論文

検索で開く
  1. Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer

    著者: Juan W. Valle, Harpreet Wasan, Daniel H. Palmer, David Cunningham, Alan Anthoney, Anthony Maraveyas, Srinivasan Madhusudan, Timothy Iveson, S. Hughes, Stephen P. Pereira, Sy Ha, John Bridgewater - New England Journal of Medicine 2010 被引用: 4,404

  2. Encorafenib, Binimetinib, and Cetuximab in BRAF V600E–Mutated Colorectal Cancer

    著者: Scott Kopetz, Axel Grothey, Rona Yaeger, Eric Van Cutsem, Jayesh Desai, Takayuki Yoshino, Harpreet Wasan, Fortunato Ciardiello, Fotios Loupakis, Yong Sang Hong, Neeltje Steeghs, Tormod Kyrre Guren, Hendrik‐Tobias Arkenau, Pilar García‐Alfonso, Per Pfeiffer, Sergey Orlov, Sara Lonardi, Elena Élez, Tae-Won Kim, Jan H.M. Schellens, Christina Guo, Asha Krishnan, Jeroen Dekervel, Van K. Morris, Aitana Calvo Ferrandiz, Line Schmidt Tarpgaard, Michael Braun, Ashwin Gollerkeri, Christopher Hunt Keir, Kati Maharry, Michael D. Pickard, Janna Christy‐Bittel, Lisa Anderson, Victor Sandor, Josep Tabernero - New England Journal of Medicine 2019 被引用: 1,465

  3. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer

    著者: Eric Van Cutsem, Andrés Cervantes, René Adam, Alberto Sobrero, J. Han van Krieken, Dan Aderka, E. Aranda Aguilar, Alberto Bardelli, Al B. Benson, G. Bodoky, Fortunato Ciardiello, André D’Hoore, Eduardo Díaz‐Rubio, Jean‐Yves Douillard, Michel Ducreux, Alfredo Falcone, Axel Grothey, Thomas Gruenberger, Karin Haustermans, Volker Heinemann, Paulo M. Hoff, C.-H. Köhne, Roberto Labianca, Pierre Laurent‐Puig, Brigette Ma, Tim Maughan, Kei Muro, Nicola Normanno, Pia Österlund, Wim J.G. Oyen, Demetris Papamichael, George Pentheroudakis, Per Pfeiffer, Timothy Price, Cornelis J.A. Punt, Jens Ricke, A. Roth, Ramón Salazar, Werner Scheithauer, Hans‐Joachim Schmoll, Josep Tabernero, Julien Taı̈eb, Sabine Tejpar, Harpreet Wasan, Takayuki Yoshino, Aziz Zaanan, Dirk Arnold - Annals of Oncology 2016 被引用: 3,449

  4. Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial

    著者: John P. Neoptolemos, Daniel H. Palmer, Paula Ghaneh, Eftychia Eirini Psarelli, Juan W. Valle, Christopher Halloran, Olusola Olusesan Faluyi, Derek O’Reilly, David Cunningham, Jonathan Wadsley, Suzanne Darby, Tim Meyer, Roopinder Gillmore, Alan Anthoney, Pehr Lind, Bengt Glimelius, Stephen Falk, Jakob R. Izbicki, Gary Middleton, Sebastian Cummins, Paul J. Ross, Harpreet Wasan, Alec McDonald, Tom Crosby, Yuk Ting, Kinnari Patel, David Sherriff, Rubin Soomal, David Borg, Sharmila Sothi, Pascal Hammel, Thilo Hackert, Richard Jackson, Markus W. Büchler - The Lancet 2017 被引用: 1,928

  5. Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study

    著者: John N Primrose, Richard Fox, Daniel H. Palmer, Hassan Malik, Rajendra Prasad, Darius Mirza, Alan Anthony, Pippa Corrie, Stephen Falk, Meg Finch-Jones, Harpreet Wasan, Paul J. Ross, Lucy Wall, Jonathan Wadsley, JEFF EVANS, Deborah Stocken, Raaj Praseedom, Yuk Ting, Brian R Davidson, John P. Neoptolemos, Timothy Iveson, James Raftery, Shihua Zhu, David Cunningham, O. James Garden, Clive Stubbs, Juan W. Valle, John Bridgewater, John Primrose, RP Fox, Helen Morement, Oscar S.H. Chan, C. Rees, Ma Yt, Tamas Hickish, Stephen Falk, Meg Finch-Jones, Ian Pope, Pippa Corrie, Tom Crosby, S. Sothi, K Sharkland, Douglas Adamson, Lucy Wall, JEFF EVANS, John Dent, U. Hombaiah, Chinenye Iwuji, Alan Anthoney, John Bridgewater, David Cunningham, Roopinder Gillmore, Paul J. Ross, S. Slater, Harpreet Wasan, Jill Waters, Juan W. Valle, Daniel H. Palmer, Hafiz Malik, John P. Neoptolemos, Olusola Olusesan Faluyi, Kate Sumpter, U. Dernedde, S Maduhusudan, G. Cogill, Caroline Archer, Timothy Iveson, Jonathan Wadsley, Suzanne Darby, Mike Peterson, AA Mukhtar, JG Thorpe, Adrian C Bateman, D. Tsang, S. Cummins, L. Nolan, Éric Beaumont, Rajendra Prasad, D. Mirza, Deborah Stocken, Raaj Praseedom, Brian R Davidson, James Raftery, Shihua Zhu, James Garden, C Stubbs, Fareeda Y. Coxon - The Lancet Oncology 2019 被引用: 1,228

  6. Encorafenib Plus Cetuximab as a New Standard of Care for Previously Treated BRAF V600E–Mutant Metastatic Colorectal Cancer: Updated Survival Results and Subgroup Analyses from the BEACON Study

    著者: Josep Tabernero, Axel Grothey, Eric Van Cutsem, Rona Yaeger, Harpreet Wasan, Takayuki Yoshino, Jayesh Desai, Fortunato Ciardiello, Fotios Loupakis, Yong Sang Hong, Neeltje Steeghs, Tormod Kyrre Guren, Hendrik-Tobias Arkenau, Pilar García‐Alfonso, Elena Élez, Ashwin Gollerkeri, Kati Maharry, Janna Christy‐Bittel, Scott Kopetz - Journal of Clinical Oncology 2021 被引用: 544

  7. Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial

    著者: Ángela Lamarca, Daniel H. Palmer, Harpreet Wasan, Paul J. Ross, Yuk Ting, Arvind Arora, Stephen Falk, Roopinder Gillmore, Jonathan Wadsley, Kinnari Patel, Alan Anthoney, Anthony Maraveyas, Timothy Iveson, Justin S. Waters, Claire Hobbs, Safia Barber, W. David J. Ryder, John Ramage, Linda Davies, John Bridgewater, Juan W. Valle - The Lancet Oncology 2021 被引用: 749

  8. Zanidatamab for HER2-amplified, unresectable, locally advanced or metastatic biliary tract cancer (HERIZON-BTC-01): a multicentre, single-arm, phase 2b study

    著者: James J. Harding, Jia Fan, Do‐Youn Oh, Hye Jin Choi, Jin Won Kim, Heung-Moon Chang, Lequn Bao, Hui‐Chuan Sun, Teresa Macarulla, Feng Xie, Jean‐Philippe Metges, Jieer Ying, John Bridgewater, Myung Ah Lee, Mohamedtaki Abdulaziz Tejani, Emerson Y. Chen, Dong Uk Kim, Harpreet Wasan, Michel Ducreux, Yuanyuan Bao, Lisa Boyken, Jiafang Ma, Phillip M. Garfin, Shubham Pant, Ghassan K. Abou‐Alfa, J. Adeva Alfonso, Massimo Aglietta, Ari David Baron, Muhammad Shaalan Beg, Paula Carrasco Aguirre, Eric X. Chen, Ying Cheng, Antonio Cubillo Gracián, Laëtitia Dahan, Filippo de Braud, Elisabetta Fenocchio, Olumide Gbolohon, Roopinder Gillmore, Marine Jary, Milind Javle, Yixing Jiang, Jung Hun Kang, Gentry George King, Madappa N. Kundranda, Laura Layos, Daneng Li, Tingbo Liang, Sara Lonardi, Omkar Marathe, Sebastián Mondaca, Andrés J. Muñoz Martín, Joon Oh Park, Roberto Pazo-Cid, Paula Ribera Fernandez, Lorenza Rimassa, Rosa Alonso, Saeed Sadeghi, Aaron J. Scott, Benjamin Tan, David Tougeron, Qiang Yan, Xiaoyu Yin, Haitao Zhao - The Lancet Oncology 2023 被引用: 247

  9. Immediate surgery compared with short-course neoadjuvant gemcitabine plus capecitabine, FOLFIRINOX, or chemoradiotherapy in patients with borderline resectable pancreatic cancer (ESPAC5): a four-arm, multicentre, randomised, phase 2 trial

    著者: Paula Ghaneh, Daniel H. Palmer, Silvia Cicconi, Richard Jackson, Christopher Halloran, Charlotte Rawcliffe, Rajaram Sripadam, Somnath Mukherjee, Zahir Soonawalla, Jonathan Wadsley, Ahmed Al-Mukhtar, Euan J. Dickson, Janet Graham, Long R. Jiao, Harpreet Wasan, Iain S. Tait, Andreas Prachalias, Paul J. Ross, Juan W. Valle, Derek O’Reilly, Bilal Al‐Sarireh, Sarah Gwynne, Irfan Ahmed, Kate Connolly, Kein-Long Yim, David Cunningham, Thomas Armstrong, Caroline Archer, Keith Roberts, Yuk Ting, Christoph Springfeld, Christine Tjaden, Thilo Hackert, Markus W. Büchler, John P. Neoptolemos - ˜The œLancet. Gastroenterology & hepatology 2022 被引用: 325

  10. The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 24th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2022

    著者: Michel Ducreux, Ghassan K. Abou‐Alfa, Tanios Bekaii‐Saab, Jordan Berlin, Andrés Cervantes, Thierry de Baère, Charis Eng, Peter R. Galle, Sharlene Gill, Thomas Gruenberger, Karin Haustermans, Ángela Lamarca, Pierre Laurent‐Puig, Josep M. Llovet, F. Lordick, Teresa Macarulla, Deborah Mukherji, Kei Muro, Radka Obermannová, Juan Manuel O’Connor, Eileen M. O’Reilly, Pia Österlund, P. A. Philip, G. Prager, Erika Ruíz‐García, Bruno Sangro, Thomas Seufferlein, Josep Tabernero, Chris Verslype, Harpreet Wasan, Eric Van Cutsem - ESMO Open 2023 被引用: 161

  11. Long-Term Outcomes and Exploratory Analyses of the Randomized Phase III BILCAP Study

    著者: John Bridgewater, Peter Fletcher, Daniel H. Palmer, Hassan Z. Malik, Raj Prasad, Darius Mirza, Alan Anthony, Pippa Corrie, Stephen Falk, Meg Finch-Jones, Harpreet Wasan, Paul Ross, Lucy Wall, Jonathan Wadsley, Thomas R. Evans, Deborah Stocken, Clive Stubbs, Raaj Praseedom, Yuk Ting Ma, Brian Davidson, John Neoptolemos, Tim Iveson, David Cunningham, O. James Garden, Juan W. Valle, John Primrose, on behalf of the BILCAP study group - Journal of Clinical Oncology 2022 被引用: 189

  12. Cancer of unknown primary: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

    著者: A. Krämer, Tilmann Bochtler, Chantal Pauli, G. Baciarello, Stefan Delorme, Kari Hemminki, Linda Mileshkin, Holger Moch, Karin A. Oien, Timothée Olivier, Anna Patrikidou, Harpreet Wasan, George Zarkavelis, George Pentheroudakis, Karim Fizazi - Annals of Oncology 2022 被引用: 197

  13. Patterns of Recurrence After Resection of Pancreatic Ductal Adenocarcinoma

    著者: Robert Jones, Eftychia‐Eirini Psarelli, Richard Jackson, Paula Ghaneh, Christopher Halloran, Daniel H. Palmer, Fiona Campbell, Juan W. Valle, Olusola Olusesan Faluyi, Derek O’Reilly, David Cunningham, Jonathan Wadsley, Suzanne Darby, Tim Meyer, Roopinder Gillmore, Alan Anthoney, Pehr Lind, Bengt Glimelius, Stephen Falk, Jakob R. Izbicki, Gary Middleton, Sebastian Cummins, Paul J. Ross, Harpreet Wasan, Alec McDonald, Tom Crosby, Yuk Ting, Kinnari Patel, David Sherriff, Rubin Soomal, David Borg, Sharmila Sothi, Pascal Hammel, Markus M. Lerch, Julia Mayerle, Christine Tjaden, Oliver Strobel, Thilo Hackert, Markus W. Büchler, John P. Neoptolemos, for the European Study Group for Pancreatic Cancer - JAMA Surgery 2019 被引用: 273

  14. Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update

    著者: Shahid A. Khan, Brian R Davidson, Robert Goldin, Nigel Heaton, John Karani, Stephen P. Pereira, William Rosenberg, Paul Tait, Simon D. Taylor‐Robinson, Andrew V. Thillainayagam, Howard C. Thomas, Harpreet Wasan - Gut 2012 被引用: 793

  15. FIGHT-302: first-line pemigatinib vs gemcitabine plus cisplatin for advanced cholangiocarcinoma with FGFR2 rearrangements

    著者: Tanios S Bekaii-Saab, Juan W. Valle, Eric Van Cutsem, Lorenza Rimassa, Junji Furuse, Tatsuya Ioka, Davide Melisi, Teresa Macarulla, John Bridgewater, Harpreet Wasan, Mitesh J. Borad, Ghassan K. Abou‐Alfa, Ping Jiang, Christine Lihou, Hui‐Ling Zhen, Ekaterine Asatiani, Luis Féliz, Arndt Vogel - Future Oncology 2020 被引用: 165

  16. Clinical efficacy and safety of anti-PD-1/PD-L1 inhibitors for the treatment of advanced or metastatic cancer: a systematic review and meta-analysis

    著者: Leitao Sun, Leyin Zhang, Jieru Yu, Yinan Zhang, Xi Pang, Chenghao Ma, Minhe Shen, Shanming Ruan, Harpreet Wasan, Shengliang Qiu - Scientific Reports 2020 被引用: 194

  17. Cediranib or placebo in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer (ABC-03): a randomised phase 2 trial

    著者: Juan W. Valle, Harpreet Wasan, Andre Lopes, Alison Backen, Daniel H. Palmer, Karen Morris, Marian Duggan, David Cunningham, Alan Anthoney, Pippa Corrie, Srinivasan Madhusudan, Anthony Maraveyas, Paul J. Ross, Justin S. Waters, W P Steward, Charlotte Rees, Sandy Beare, Caroline Dive, John Bridgewater - The Lancet Oncology 2015 被引用: 280

  18. Molecular profiling of BRAF-V600E-mutant metastatic colorectal cancer in the phase 3 BEACON CRC trial

    著者: Scott Kopetz, Danielle Murphy, Jie Pu, Fortunato Ciardiello, Jayesh Desai, Eric Van Cutsem, Harpreet Wasan, Takayuki Yoshino, Hedieh Saffari, Xiaosong Zhang, Phineas T. Hamilton, Tao Xie, Rona Yaeger, Josep Tabernero - Nature Medicine 2024 被引用: 73

  19. Encorafenib, cetuximab and chemotherapy in BRAF-mutant colorectal cancer: a randomized phase 3 trial

    著者: Scott Kopetz, Takayuki Yoshino, Eric Van Cutsem, Cathy Eng, Tae Won Kim, Harpreet Wasan, Jayesh Desai, Fortunato Ciardiello, Rona Yaeger, Tim Maughan, Elena Beyzarov, Xiaoxi Zhang, Graham Ferrier, Xiaosong Zhang, Josep Tabernero - Nature Medicine 2025 被引用: 101

  20. Addition of ramucirumab or merestinib to standard first-line chemotherapy for locally advanced or metastatic biliary tract cancer: a randomised, double-blind, multicentre, phase 2 study

    著者: Juan W. Valle, Arndt Vogel, Crystal S. Denlinger, Aiwu Ruth He, Li‐Yuan Bai, Р. В. Орлова, Eric Van Cutsem, Jorge Adeva, Li‐Tzong Chen, Radka Obermannová, Thomas J. Ettrich, Jen‐Shi Chen, Harpreet Wasan, Allicia C. Girvan, Wei Zhang, Jiangang Liu, Chunlao Tang, Philip J. Ebert, Amit Aggarwal, Samuel McNeely, Brian A. Moser, Joana Oliveira, Roberto Carlesi, Richard A. Walgren, Do‐Youn Oh - The Lancet Oncology 2021 被引用: 66

  21. Axitinib plus gemcitabine versus placebo plus gemcitabine in patients with advanced pancreatic adenocarcinoma: a double-blind randomised phase 3 study

    著者: Hedy L. Kindler, Tatsuya Ioka, D. J. Richel, Jaafar Bennouna, Richard Létourneau, Takuji Okusaka, Akihiro Funakoshi, Junji Furuse, Young Suk Park, Shinichi Ohkawa, Gregory M. Springett, Harpreet Wasan, Peter C. Trask, Paul Bycott, Alejandro D. Ricart, Sinil Kim, Eric Van Cutsem - The Lancet Oncology 2011 被引用: 396

  22. Gemcitabine-based or capecitabine-based chemoradiotherapy for locally advanced pancreatic cancer (SCALOP): a multicentre, randomised, phase 2 trial

    著者: Somnath Mukherjee, Chris Hurt, John Bridgewater, Stephen Falk, Sebastian Cummins, Harpreet Wasan, Tom Crosby, Catherine Jephcott, Rajarshi Roy, Ganesh Radhakrishna, Alec McDonald, Ruby Ray, George Joseph, John Staffurth, Ross A. Abrams, Gareth Griffiths, Tim Maughan - The Lancet Oncology 2013 被引用: 354

  23. Advanced Intrahepatic Cholangiocarcinoma: Post Hoc Analysis of the ABC-01, -02, and -03 Clinical Trials

    著者: Ángela Lamarca, Paul J. Ross, Harpreet Wasan, Richard Hubner, Mairéad G. McNamara, Andre Lopes, Prakash Manoharan, Daniel G. Palmer, John Bridgewater, Juan W. Valle - JNCI Journal of the National Cancer Institute 2019 被引用: 165

  24. Cisplatin and gemcitabine for advanced biliary tract cancer: a meta-analysis of two randomised trials

    著者: Juan W. Valle, Junji Furuse, Mark Jitlal, Sandy Beare, Nobumasa Mizuno, Harpreet Wasan, John Bridgewater, Takuji Okusaka - Annals of Oncology 2013 被引用: 396